Abstract. Reactive oxygen species (ROS) are involved in the signaling pathway and are triggered by angiogenic factors, including vascular endothelial growth factor and angiopoietins. 4-isothiocyanate-2, 2, 6, 6-tetramethyl piperidinooxyl (4-ISO-Tempo) is one of the nitroxides that exhibits antioxidant activity. However, the anti-angiogenic effect of 4-ISO-Tempo remains unknown. The aim of this study was to investigate the effect of 4-ISO-Tempo on tumor proliferation and angiogenesis as well as its underlying mechanisms. Our results revealed that 4-ISO-Tempo significantly inhibited the viability of neoplastic and endothelial cells. Furthermore, the effective concentration of 4-ISO-Tempo on human microvascular endothelial cell 1 (HMEC-1) was lower than that on human lung adenocarcinoma A549 and human colon cancer SW620 cells. This suggested that endothelial cells were more sensitive to 4-ISO-Tempo than tumor cells. Furthermore, we demonstrated that 4-ISO-Tempo also suppressed secretion of matrix metallo proteinase (MMP)-2 and MMP-9, and migration and tube formation of HMEC-1 cells. The mechanism is attributed to the decreasing ROS generation and further phosphorylation of vascular endothelial growth factor receptor 2 and Tie2. Our findings suggest that 4-ISO-Tempo should be investigated for its usefulness in anti-angiogenesis therapies.
Introduction
The development of a vascular network is considered to be a rate-limiting step for tumor growth, invasion and metastasis (1) . Tumor angiogenesis is defined as the formation of new capillary from pre-existing vessels. Early studies demonstrated that microvessel density, a measure of angiogenesis, was highly correlated with poorer survival in primary breast, prostate, gastric, non-small cell lung and cervical cancers (2-4). Therefore, tumor angiogenesis is a promising target for the treatment of solid cancers. A number of growth factors and inflammatory cytokines are known to promote angiogenesis, including vascular endothelial growth factor (VEGF), angiopoietins (Angs) and interleukin-8 (5-7). Among these, VEGF is one of the most significant pro-angiogenic factors, which binds to kinase insert domain-containing receptor (KDR/FLk-1/VEGFR2), particularly expressed in endothelial cells, to mediate its angiogenic effect (8) . Accumulating evidence has revealed that VEGF stimulates autophosphorylation of VEGF receptor 2 (VEGFR2) and then initiates the signaling cascade involving the PKC-Raf1-MEK-ERK1/2 and PI-3K/AKT/eNOS pathways to exert angiogenic and pro-survival effects on endothelial cells (9, 10) . Subsequently, inhibition of VEGFR2 signaling by small molecule inhibitors was demonstrated to significantly suppress the growth of a variety of solid tumors (11) . In addition, bevacizumab, a neutralizing antibody to VEGF, has been applied to prolong survival in patients with malignant colon cancer, and is currently being tested with other tumor types (12) .
However, new blood vessels stimulated by VEGF alone are not mature. Angiopoietin 1 (Ang1) is another significant pro-angiogenic factor. Unlike VEGF, Ang1 is required for vascular remodeling and maturation during angiogenesis. After binding to its receptor Tie2, Ang1 stimulates autophosphorylation of Tie2 and then activates downstream signaling molecules, including AKT and ERK, which promotes stabilization of the immature endothelial cell network (13) . It is generally accepted that VEGF/VEGFR2 signaling is essential for new blood vessel formation, while Ang1/Tie2 signaling is critical for blood vessel maturation and stabilization. Therefore, the inhibition of the two pathways exhibits additive anti-angiogenic effects. Accumulating evidence has indicated that masses of reactive oxygen species (ROS) induce cell death, while low concentrations of ROS play a crucial role in tumor progression by acting as a signaling molecule (14, 15) . ROS are also involved in the processes of angiogenesis, including proliferation, degradation of the extracellular matrix, migration, and differentiation of endothelial cells. A number of antioxidants exhibit anti-angiogenic activity.
4-isothiocyanate
The nitroxides are a group of metal-free, low molecular weight, water-soluble and stable free radicals which are widely used in electron paramagnetic resonance spectroscopy (16, 17) . Increasing evidence has revealed that nitroxides have antioxidative and anticancer activity. Gariboldi et al also demonstrated that treatment with nitroxide decreased the rate of tumor vascularization and reduced microvessel density (18) . 4-isothiocyanate-2,2,6,6-tetramethyl piperidinooxyl (4-ISO-Tempo) is one of the nitroxides that exhibits significant antioxidant activity. However, the anti-neoplastic and anti-angiogenic effect of 4-ISO-Tempo has yet not been reported. The main aim of the present study was to investigate the anti-angiogenic activity of 4-ISO-Tempo and its underlying molecular mechanism.
Materials and methods
Materials and reagents. 4-ISO-Tempo was a gift from the State Key Laboratory of Applied Organic Chemistry, Lanzhou University (Lanzhou, China). It was dissolved in dimethylsulfoxide. MCDB131 medium, epidermal growth factor (EGF), hydrocortisone, sulforhodamine B (SRB) sodium salt, gelatin and 2',7'-Dichlorofluorescin diacetate (DCFH-DA) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Leibovitz's L-15 medium and Dulbecco's modified Eagle's medium (DMEM) were purchased from Gibco Life Technologies (Carlsbad, CA, USA). Fetal bovine serum (FBS) was purchased from Lanzhou HyClone (Lanzhou, China). Matrigel was purchased from Becton Dickinson (Bedford, MA, USA). Millicell cell culture inserts were purchased from Millipore (Bedford, MA, USA). Recombinant human VEGF and recombinant human Ang1 were purchased from Peprotech (Rocky Hill, NJ, USA). Antibodies to VEGFR2, Tie2 and actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Phospho-VEGFR2 (Tyr 1175) rabbit mAb and Phospho-Tie2 (Tyr 992) antibody were purchased from Cell Signaling Technology (Beverly, MA, USA). Other agents were of analytical purity.
Cell line and cell culture. Human microvascular endothelial cells (HMEC-1) were cultured in MCDB131 medium containing 20% FBS, 10 ng/ml EGF and 1 µg/ml hydrocortisone. Human colon carcinoma cells (SW620) were cultured in Leibovitz's L-15 medium supplemented with 10% FBS. Human lung adenocarcinoma cells (A549) were cultured in DMEM with 10% FBS. Cells were incubated in an atmosphere of 5% CO 2 at 37˚C.
Cell viability assay. The effect of 4-ISO-Tempo on the viability of various cell lines was examined with SRB assay (19, 20) . Briefly, HMEC-1, SW620 and A549 cells were seeded in 96-well plates. Following overnight incubation, the cells were treated with or without 4-ISO-Tempo for 24 and 72 h. The culture medium was then discarded. 10% trichloroacetic acid (100 µl) was added to each well and the plates were incubated at 4˚C for 1 h. Each well was stained with 100 µl 0.4% SRB for 30 min, washed with 1% acetic acid to remove unbound dye and left to dry overnight. The protein-bound SRB dye was solubilized with 100 µl 10 mM Tris base. The optical density in each well was read with a microplate reader (Infinite® 200 PRO series; Tecan Group Ltd., Männedorf, Switzerland) at 515 nm.
Gelatin zymography. Matrix metalloproteinase (MMP)-2 and MMP-9 gelatinase activity was measured as described in a previous study (21) with slight modification. HMEC-1 cells were treated with various concentrations of 4-ISO-Tempo in the absence of serum for 24 h at 37˚C. The conditioned medium was collected and centrifuged. Supernatant was collected and separated by 7.5% sodium dodecyl sulphate (SDS) polyacrylamide gel containing 1% gelatin. Then the gels were washed for 1 h at room temperature to remove SDS and incubated in the incubation buffer [50 mM Tris-HCl (pH 7.5), 0.2 M NaCl and 5 mM CaCl 2 ] for 36 h at 37˚C. The gel was stained for 1 h with 0.5% Coomassie brilliant blue R-250 and destained with 25% methanol and 7.5% acetic acid. Gelatinase activity was detected as clear bands against a dark blue background.
Cell migration assay. Endothelial cell migration assay was measured as described previously (19) with slight modification. Briefly, 2x10 5 HMEC-1 cells in serum-free culture medium with or without 4-ISO-Tempo were added into the upper chamber cell culture inserts. The lower chamber contained 600 µl MCDB131 medium supplemented with 20% FBS. Following incubation for 24 h, non-migrated cells were scraped with a cotton swab. The bottom side of the membrane was fixed by ethanol and then stained with 0.1% crystal violet. The migrated cells were then washed three times with phosphate-buffered saline (PBS). Images of at least five randomly selected microscopic fields were captured under light microscopy. The number of migrated cells was counted using ImagePro Plus software (Media Cybernetics, Inc., Rockville, MD, USA).
Tube formation assay. Tube formation assay was measured as described previously (19) with slight modification. HMEC-1 cells at a density of 8x10 4 /well were seeded in Matrigel-coated 96-well plates in MCDB131 medium containing various concentrations of 4-ISO-Tempo. After 8 h, images were captured under an inverted microscope (Olympus IX41; Olympus Corporation, Tokyo, Japan) and the tubular length was measured using ImagePro Plus software.
Western blot assay. Western blot assay was assessed as previously described (22) with slight modification. HMEC-1 cells were pretreated with various concentrations of 4-ISO-Tempo for 24 h and then stimulated with 50 ng/ml VEGF for 10 min or 200 ng/ml Ang1 for 30 min. Cells were lysed in lysis buffer with proteinase inhibitors (50 mM NaF, 0.2 mM Na 3 VO 4 , 1 mM phenylmethane sulfonyl fluoride, 2 µg/ml aprotinin and 2 µg/ml leupeptin). Equal amounts of protein for each sample were separated by SDS polyacrylamide and transferred onto the polyvinylidene fluoride membrane. The membrane was then blocked and probed with specific antibodies. Horseradish peroxidase-conjugated secondary antibodies were used to probe the antibody. Immunoreactive bands were detected with chemiluminescence.
Intracellular ROS measurement. The intracellular ROS were measured as described previously (23) with slight modification. HMEC-1 cells were seeded in a six-well plate and treated with 4-ISO-Tempo in serum-free medium for 4 h. Then the cells were left untreated or treated with 50 ng/ml VEGF for 10 min and incubated with 10 µM DCFH-DA for 30 min. The cells were washed twice with PBS and the fluorescent images were captured under a contrast fluorescence microscope (Olympus BX51; Olympus Corporation). The fluorescent intensity was measured using ImagePro Plus software.
Statistical analysis. Data are expressed as the means ± standard error. Statistical significance was evaluated using Student's t-test. P<0.05 was considered to indicate a statistically significant difference. 
Results
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we investigated the effect of 4-ISO-Tempo on endothelial cell migration. As shown in Fig. 4 , a large amount of HMEC-1 cells migrated to the lower side of the filter through the Transwell membrane. However, the amount decreased significantly when 4-ISO-Tempo was added to the upper chamber, with inhibition rates of 31.3, 29.9, 52.8, 58.7 and 73.6% at concentrations of 0.156, 0.312, 1.625, 1.25 and 2.5 µg/ml.
Effect of 4-ISO-Tempo on tube formation of endothelial cells.
Since the differentiation of endothelial cells is required for angiogenesis, we tested the effect of 4-ISO-Tempo on the capillary-like structure formation of endothelial cells.
The capillary-like structure formation was inhibited by 4-ISO-Tempo with inhibition rates of 15.9, 36.3, 62.3 and 75.9% at concentrations of 0.156, 0.312, 0.625 and 1.25 µg/ml. There were no completely formed networks in the 2.5 µg/ml treatment group (Fig. 5) .
Effect of 4-ISO-Tempo on VEGFR2 phosphorylation in HMEC-1.
As a specific mitogen of endothelial cells, VEGF plays a vital role in endothelial cell activation, proliferation, migration and survival by activating VEGF/VEGFR2 signaling cascades (24) . To evaluate the molecular mechanism by which 4-ISO-Tempo inhibited angiogenesis, we examined We observed that 4-ISO-Tempo was unable to affect the basal expression of VEGFR2, while it strongly blocked phosphorylation of VEGFR2 at Tyr 1175 in a dose-dependent manner after stimulating VEGF165 (50 ng/ml) for 10 min (Fig. 6 ).
Our results demonstrated that 4-ISO-Tempo may suppress angiogenesis by interrupting VEGF-induced VEGFR2 phosphorylation.
Effect of 4-ISO-Tempo on Tie2 phosphorylation in HMEC-1.
Ang1 mediates vessel maturation and integrity by favoring the recruitment of pericytes and smooth muscle cells (25) . During angiogenesis, Ang1 is able to induce the phosphorylation of Tie2, which is subsequently able to transduce a biological signal to endothelial cells (25) . As shown in 
Effect of 4-ISO-Tempo on ROS generation of endothelial cells.
We subsequently investigated the effect of 4-ISO-Tempo on ROS generation in HMEC-1 cells. As shown in Fig. 8 , treatment with VEGF increased intracellular ROS production, while 4-ISO-Tempo decreased this VEGF-induced effect. Therefore, it was hypothesized that 4-ISO-Tempo inhibited endothelial cell growth, migration and tube-like formation by reducing ROS generation.
Discussion
Tumor angiogenesis is essential for the growth of solid tumors, since tumors remain in the dormant phase for a long time in the absence of the initiation of blood vessel formation. Usually, the tumor mass diameter does not exceed 1-2 mm without involving angiogenesis, and this is the size limit for simple diffusion of nutrients and oxygen (1) . Therefore, the angiogenesis process could be an significant target in suppressing tumor growth and metastasis. There are numerous complex steps involved in angiogenesis, including basement membrane degradation, migration, proliferation and formation of capillary tubes of endothelial cells. Endothelial cells are the main players in the angiogenesis process and could be a particular target for anti-angiogenic therapy. Our results revealed that 4-ISO-Tempo significantly inhibited A549 and SW620 cell viability. In addition, 4-ISO-Tempo markedly inhibited the proliferation of HMEC-1 cells in a concentration-dependent manner, and the effective concentration of 4-ISO-Tempo in (26, 27) . The breakdown of the tissue matrix by MMPs to facilitate the movement of newly formed endothelial cells for vessel formation is a critical step in angiogenesis (28) . MMP-2 and MMP-9 are overexpressed in invasive prostate cancer, and facilitate the invasion of tumor and endothelial cells (27, 29) . 4-ISO-Tempo notably reduced the secretion of MMP-2 and MMP-9. In addition, it significantly inhibited the migration and capillary-like structure formation of endothelial cells in a concentration-dependent manner in vitro. This indicated that 4-ISO-Tempo suppressed neovascularization through a multi-step process in vitro.
During initial angiogenesis and vasculogenesis, a variety of growth factors and cytokines are upregulated, and exert their functions through autocrine or paracrine actions. Of these, VEGF is the most significant mitogenic and survival factor for vascular endothelial cells, since its receptors are selectively located in endothelial cells (30) . There is now considerable evidence that VEGFR2 is the main mediator of VEGF-driven responses in endothelial cells, and it is considered to be a crucial signal transducer in physiological and pathological angiogenesis. The VEGF binds to VEGFR2, leading to receptor dimerization and phosphorylation at Tyr 1175, which has been identified as a major autophosphorylation site and is critical in mediating migratory responses (31, 32) . Our results demonstrated that 4-ISO-Tempo had no effect on the expression of VEGFR2, whereas it strongly inhibited phosphorylation of VEGFR2 at Tyr 1175 after stimulating VEGF for 10 min.
The activation of Tie2 promotes endothelial cell migrapromotes endothelial cell migrapromotes endothelial cell migration and survival as well as the maturation of new blood vessels. Blockade of the Ang1/Tie2 and VEGF/VEGFR2 signaling pathways strengthened the anti-VEGF therapy efficacy on angiogenesis (33, 34) . In our study, we observed that 4-ISO-Tempo blocked the phosphorylation of Tie2 at Tyr 992 after stimulating Ang1 (200 ng/ml) for 30 min. These results demonstrated that 4-ISO-Tempo not only inhibited the phosnot only inhibited the phosphorylation of VEGFR2 but also the phosphorylation of Tie2, indicating that 4-ISO-Tempo is an anti-angiogenic agent with bifunctional inhibition of sprouting angiogenesis and maturation of blood vessels.
ROS have been suggested as significant mediators of angiogenesis (35) . VEGF promotes proliferation and migra-. VEGF promotes proliferation and migration of endothelial cells via VEGFR2. ROS are involved in VEGFR2 autophosphorylation and angiogenic-related responses in endothelial cells. A previous study revealed that diphenyleneiodonium, a nicotinamide adenine dinucleotide phosphate-oxidase inhibitor, blocked the phosphorylation of AKT and p44/42 MAPK via inhibition of ROS generation induced by Ang1 (36) . In the present study, stimulation with VEGF also induced massive ROS production by endothelial cells. This result is consistent with that of the aforementioned study by Chen et al (36) . However, pretreatHowever, pretreatment with 4-ISO-Tempo significantly inhibited VEGF-induced ROS generation, which indicated that the inhibitory effect of 4-ISO-Tempo on VEGFR2 and Tie2 phosphorylation was attributed to decreasing ROS generation.
4-ISO-Tempo exhibits anti-neoplastic activity in vitro.
In addition, 4-ISO-Tempo also inhibits proliferation, migration and tube formation of HMEC-1 cells. These results may be partly attributed to reducing ROS generation and further inhibiting phosphorylation of VEGFR2 and Tie2. The most promising feature of 4-ISO-Tempo is its ability to inhibit VEGFR2 and Tie2 phosphorylation in the VEGF/VEGFR2 and Ang1/Tie2 pathway simultaneously to minimize the possibility of resistance to anti-VEGF therapy in angiogenesis. Although the exact mechanism of anti-angiogenesis of 4-ISO-Tempo remains elusive, we have demonstrated that this agent is a potent inhibitor of angiogenesis, suggesting that 4-ISO-Tempo could be investigated for its usefulness in anti-angiogenesis therapies.
